| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |